Tech Center 1600 • Art Units: 1634
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16986954 | THERAPEUTIC EXTRACELLULAR VESICLES | Final Rejection | Ohio State Innovation Foundation |
| 18005511 | TROPHOBLAST STEM CELL-LIKE CELLS CAPABLE OF DIFFERENTIATING INTO PLACENTA-CONSTITUTING CELLS, AND METHOD FOR PRODUCING SAME | Non-Final OA | TOHOKU UNIVERSITY |
| 17767540 | CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS | Final Rejection | Regents of the University of Minnesota |
| 17642244 | NUCLEIC ACID SEQUENCE FOR REGULATION OF TRANSGENE EXPRESSION | Final Rejection | SORBONNE UNIVERSITE |
| 17811403 | COMPOSITION FOR INDUCING DIFFERENTIATION INTO INSULIN-PRODUCING CELLS, AND USE THEREOF | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 17779567 | Method for Producing Brown Adipocytes | Final Rejection | Kyoto Prefectural Public University Corporation |
| 18255868 | METHODS FOR PURIFICATION OF AAV VECTORS BY AFFINITY CHROMATOGRAPHY | Non-Final OA | PFIZER INC. |
| 17759327 | METHOD FOR CULTURING FACTOR-INTRODUCED CELLS | Final Rejection | Koji TANABE |
| 18008139 | BACTERIAL STRAINS FOR DNA PRODUCTION | Non-Final OA | ModernaTX, Inc. |
| 16098464 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY | Final Rejection | Editas Medicine, Inc. |
| 17790059 | GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47 | Final Rejection | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| 18505543 | METHOD OF PRODUCING ANTIBODIES FROM SINGLE PLASMA CELLS | Non-Final OA | Daro Zist Azma Oxin |
| 18042635 | COMPOSITION FOR PROMOTING DIFFERENTIATION OF NEURAL STEM CELLS INTO DOPAMINERGIC NEURONS | Non-Final OA | SUNGKWANG MEDICAL FOUNDATION |
| 17791113 | Decellularized Nerve Graft and Method of Manufacturing the Same | Non-Final OA | L&C Bio Co., Ltd. |
| 18262959 | Compositions and Methods for Treating Hereditary Angioedema | Non-Final OA | Spark Therapeutics, Inc. |
| 17760658 | Product for Therapy and Methods | Final Rejection | The University of Bristol |
| 17787719 | RAT SPERM FREEZING METHOD AND IN VITRO FERTILIZATION METHOD | Non-Final OA | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY |
| 17998563 | METHOD FOR PRODUCING TARGET CELLS, METHOD FOR PRODUCING PRODUCT USING TARGET CELLS, AND SERUM-FREE MEDIUM | Non-Final OA | MYORIDGE CO. LTD. |
| 17639281 | METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES | Non-Final OA | Exuma Biotech Corp. |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | Non-Final OA | GN Corporation Co Ltd |
| 17415642 | CRISPR-CAS SYSTEM FOR GENE THERAPY | Final Rejection | AZIENDA OSPEDALIERA UNIVERSITARIA SENESE (AOUS) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy